• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疣状表皮发育不良中的细胞介导免疫

Cell-mediated immunity in epidermodysplasia verruciformis.

作者信息

Gliński W, Jablonska S, Langner A, Obalek S, Haftek M, Proniewska M

出版信息

Dermatologica. 1976;153(4):218-27. doi: 10.1159/000251060.

DOI:10.1159/000251060
PMID:1017532
Abstract

Investigations were performed in 6 cases of epidermodysplasia verruciformis and 2 healthy family members. Nonspecific cell-mediated immunity (CMI) was studied by measuring response to phytohemagglutinin (PHA) and concanavalin A (Con A), percentrages of E- and EAC-rosette-forming lymphocytes, bacterial skin tests, and allergic reactions to dinitrochloro-benzene (DNCB). Impairment of CMI was manifested by reduction in the percentage of E rosettes, and lowered response to PHA, and- to a lesser degree- to Con A. The immune response to DNCB sensitization was invariably negative. Impairment of CMI was greater in cases of long duration and with extensive lesions. The cases of similar duration and extent of lesions, which never showed tendency to tumor formation, were not different in CMI in comparison with cases with numerous tumors. Only in cases with very advanced tumors CMI was impaired parallel to the gravity of the patient's general condition.

摘要

对6例疣状表皮发育不良患者及2名健康家庭成员进行了研究。通过检测对植物血凝素(PHA)和刀豆球蛋白A(Con A)的反应、E花环和EAC花环形成淋巴细胞的百分比、皮肤细菌试验以及对二硝基氯苯(DNCB)的过敏反应,研究了非特异性细胞介导免疫(CMI)。CMI受损表现为E花环百分比降低,对PHA的反应降低,对Con A的反应降低程度较小。对DNCB致敏的免疫反应始终为阴性。病程长且皮损广泛的病例中CMI受损更严重。病程和皮损范围相似但从未有肿瘤形成倾向的病例,与有大量肿瘤的病例相比,CMI没有差异。只有在肿瘤非常晚期的病例中,CMI才与患者的全身状况严重程度平行受损。

相似文献

1
Cell-mediated immunity in epidermodysplasia verruciformis.疣状表皮发育不良中的细胞介导免疫
Dermatologica. 1976;153(4):218-27. doi: 10.1159/000251060.
2
Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis.疣状表皮发育不良患者的非特异性细胞介导免疫
J Dermatol. 2003 Mar;30(3):203-9. doi: 10.1111/j.1346-8138.2003.tb00372.x.
3
T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5.
Dermatologica. 1981;162(3):141-7. doi: 10.1159/000250262.
4
Cell-mediated immunity (CMI) in psoriasis.银屑病中的细胞介导免疫(CMI)。
Arch Immunol Ther Exp (Warsz). 1978;26(1-6):755-60.
5
Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.皮肤对二硝基氯苯的反应性、PHA诱导的淋巴细胞增殖反应与外周血E花环之间的相关性。
Clin Exp Immunol. 1975 Feb;19(2):327-33.
6
Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.癌症患者的细胞介导免疫:临床分期与免疫能力之间的相关性。
Cancer. 1976 Sep;38(3):1149-54. doi: 10.1002/1097-0142(197609)38:3<1149::aid-cncr2820380316>3.0.co;2-x.
7
Comparative studies on cell-mediated immunity in patients with different warts.不同疣病患者细胞介导免疫的比较研究。
Dermatologica. 1980;161(2):73-83. doi: 10.1159/000250336.
8
[Epidermodysplasia verruciformis (2 cases). Immunological study (author's transl)].疣状表皮发育不良(2例)。免疫学研究(作者译)
Ann Dermatol Venereol. 1980 Jul;107(7):611-9.
9
Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.格雷夫斯病中,外周血T和B淋巴细胞、用植物血凝素进行体外刺激以及用2,4-二硝基氯苯进行致敏
J Clin Endocrinol Metab. 1976 Mar;42(3):583-7. doi: 10.1210/jcem-42-3-583.
10
Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.妊娠滋养细胞疾病中细胞介导免疫的临床研究:葡萄胎和滋养细胞肿瘤患者的非特异性细胞免疫能力
Microbiol Immunol. 1981;25(4):387-401. doi: 10.1111/j.1348-0421.1981.tb00040.x.

引用本文的文献

1
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis.将Tmc6/Ever1或Tmc8/Ever2缺陷的FVB小鼠感染MmuPV1作为典型疣状表皮发育不良中β型人乳头瘤病毒的模型。
PLoS Pathog. 2025 Jan 15;21(1):e1012837. doi: 10.1371/journal.ppat.1012837. eCollection 2025 Jan.
2
Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.疣状表皮发育不良:对人β乳头瘤病毒免疫的先天性缺陷。
Front Microbiol. 2018 Jun 12;9:1222. doi: 10.3389/fmicb.2018.01222. eCollection 2018.
3
The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.
跨膜通道样蛋白家族和人乳头瘤病毒:对疣状表皮发育不良和向鳞状细胞癌进展的深入了解。
Oncoimmunology. 2014 Jan 1;3(1):e28288. doi: 10.4161/onci.28288. Epub 2014 Apr 15.
4
Warts and all: human papillomavirus in primary immunodeficiencies.有好有坏:原发性免疫缺陷中的人乳头瘤病毒。
J Allergy Clin Immunol. 2012 Nov;130(5):1030-48. doi: 10.1016/j.jaci.2012.07.049. Epub 2012 Oct 1.
5
EVER2 deficiency is associated with mild T-cell abnormalities.EVER2 缺乏与轻微的 T 细胞异常有关。
J Clin Immunol. 2013 Jan;33(1):14-21. doi: 10.1007/s10875-012-9749-1. Epub 2012 Aug 19.
6
EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation.EVER 蛋白是天然抗人乳头瘤病毒屏障的关键要素,其在 T 细胞激活时受到调控。
PLoS One. 2012;7(6):e39995. doi: 10.1371/journal.pone.0039995. Epub 2012 Jun 28.
7
The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.EVER蛋白作为抵抗乳头瘤病毒的天然屏障:对人乳头瘤病毒感染发病机制的新见解。
Microbiol Mol Biol Rev. 2009 Jun;73(2):348-70. doi: 10.1128/MMBR.00033-08.
8
Immunopathology of papillomavirus-induced warts and skin cancers in immunodepressed and immunosuppressed patients.免疫抑制和免疫低下患者中乳头瘤病毒诱发的疣和皮肤癌的免疫病理学
Springer Semin Immunopathol. 1982;5(1):53-62. doi: 10.1007/BF00201956.
9
Immunopathology of papillomavirus-induced tumors in different tissues.乳头瘤病毒在不同组织中诱导肿瘤的免疫病理学
Springer Semin Immunopathol. 1982;5(1):33-53. doi: 10.1007/BF00201955.
10
The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions.在子宫颈人乳头瘤病毒(HPV)病变中发现的免疫反应性细胞类型与这些病变后续行为之间的关系。
Arch Gynecol. 1984;234(3):189-96. doi: 10.1007/BF00570755.